NSAID Use and the Risk of Parkinson’s Disease

[1]  Houeto Jean-Luc.  [Parkinson's disease]. , 2022, La Revue du praticien.

[2]  H. Braak,et al.  Invited Article: Nervous system pathology in sporadic Parkinson disease , 2008, Neurology.

[3]  B. Carleton,et al.  Non-steroidal anti-inflammatory drug use and the risk of Parkinson disease: A retrospective cohort study , 2008, Journal of Clinical Neuroscience.

[4]  A H V Schapira,et al.  Progress in neuroprotection in Parkinson’s disease , 2008, European journal of neurology.

[5]  P. Carvey,et al.  Neuroinflammation and Peripheral Immune Infiltration in Parkinson's Disease: An Autoimmune Hypothesis , 2008, Cell transplantation.

[6]  P. Mcgeer,et al.  Glial reactions in Parkinson's disease , 2008, Movement disorders : official journal of the Movement Disorder Society.

[7]  A. Schapira.  Mitochondria in the aetiology and pathogenesis of Parkinson's disease , 2008, The Lancet Neurology.

[8]  J. Nutt,et al.  Combined effects of smoking, coffee, and NSAIDs on Parkinson's disease risk , 2008, Movement disorders : official journal of the Movement Disorder Society.

[9]  B. Ritz,et al.  Nonsteroidal anti-inflammatory drugs may protect against Parkinson disease , 2007, Neurology.

[10]  A. Hofman,et al.  Nonsteroidal Anti-Inflammatory Drugs and the Risk of Parkinson Disease , 2007, Neuroepidemiology.

[11]  M. Asanuma,et al.  Common anti-inflammatory drugs are potentially therapeutic for Parkinson’s disease? , 2007, Experimental Neurology.

[12]  P. Mcgeer,et al.  Therapeutic approaches to inflammation in neurodegenerative disease , 2007, Current opinion in neurology.

[13]  M. Hallett,et al.  The Etiopathogenesis of Parkinson Disease and Suggestions for Future Research. Part II , 2007, Journal of neuropathology and experimental neurology.

[14]  W. Scott,et al.  Smoking, caffeine, and nonsteroidal anti-inflammatory drugs in families with Parkinson disease. , 2007, Archives of neurology.

[15]  D. Maraganore,et al.  Immunologic diseases, anti-inflammatory drugs, and Parkinson disease: A case-control study , 2006, Neurology.

[16]  M. Etminan,et al.  NSAID use and the risk of Parkinson's disease. , 2006, Current drug safety.

[17]  W. Kukull,et al.  Nonsteroidal anti‐inflammatory drugs and risk of Parkinson's disease , 2006, Movement disorders : official journal of the Movement Disorder Society.

[18]  A. Członkowska,et al.  Ibuprofen and the mouse model of Parkinson's disease , 2006, Annals of neurology.

[19]  Q. Smith,et al.  Brain Uptake of Nonsteroidal Anti-Inflammatory Drugs: Ibuprofen, Flurbiprofen, and Indomethacin , 2006, Pharmaceutical Research.

[20]  M. Hernán,et al.  Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease , 2006, Neurology.

[21]  Eric Jacobs,et al.  Nonsteroidal antiinflammatory drug use and the risk for Parkinson's disease , 2005, Annals of neurology.

[22]  D. Grosset,et al.  The role of radiotracer imaging in Parkinson disease , 2005, Neurology.

[23]  K. Soliman,et al.  Ibuprofen and apigenin induce apoptosis and cell cycle arrest in activated microglia , 2005, Neuroscience Letters.

[24]  W. Willett,et al.  Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease. , 2003, Archives of neurology.

[25]  M. Beal.  Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease , 2003, Annals of the New York Academy of Sciences.

[26]  D. Casper,et al.  Ibuprofen protects dopaminergic neurons against glutamate toxicity in vitro , 2000, Neuroscience Letters.

[27]  Terina N. Martinez,et al.  Neuroinflammation in Parkinson's disease: is there sufficient evidence for mechanism-based interventional therapy? , 2008, Frontiers in bioscience : a journal and virtual library.

[28]  P. Mcgeer,et al.  The Role of Anti-Inflammatory Agents in Parkinson’s Disease , 2007, CNS drugs.